Dec 2, 2021
Ad hoc announcement pursuant to Art. 53 LR St. Gallen, Switzerland, 02 December 2021 – Due to current market speculations, Vifor Pharma Group states the following: Vifor Pharma Group...
Nov 30, 2021
Ad hoc announcement pursuant to Art. 53 LR Colin Bond to retire as Chief Financial Officer of Vifor Pharma Group Succession recruitment ongoing St. Gallen, Switzerland, 30 November 2021 - Vifor...
Nov 26, 2021
Iron Deficiency Day unites a strong international coalition dedicated to raising international awareness on the serious health impact of iron deficiency and iron deficiency anemia1 Patient access...
Nov 22, 2021Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG
Ad hoc announcement pursuant to Art. 53 LR Sanifit Therapeutics and Inositec AG, both clinical stage biopharmaceutical companies, are developing first-in-class treatments for progressive vascular...
Nov 12, 2021
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Committee for Medicinal Products for Human Use (CHMP) recommends approval of first orally administered therapy for the treatment of ANCA-associated...